A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-Yte, Has an Extended Half-Life in Healthy Adults
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01285-13
Full Text
Open PDFAbstract
Available in full text
Date
September 30, 2013
Authors
Publisher
American Society for Microbiology